These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29406942)

  • 1. Heavy Heart: The Economic Burden of Heart Disease in the United States Now and in the Future.
    Foy AJ; Mandrola JM
    Prim Care; 2018 Mar; 45(1):17-24. PubMed ID: 29406942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Kazi DS; Elkind MSV; Deutsch A; Dowd WN; Heidenreich P; Khavjou O; Mark D; Mussolino ME; Ovbiagele B; Patel SS; Poudel R; Weittenhiller B; Powell-Wiley TM; Joynt Maddox KE;
    Circulation; 2024 Jul; 150(4):e89-e101. PubMed ID: 38832515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of cardiology: utilization and costs of care.
    Steinwachs DM; Collins-Nakai RL; Cohn LH; Garson A; Wolk MJ
    J Am Coll Cardiol; 2000 Apr; 35(5 Suppl B):91B-98B. PubMed ID: 10757374
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of cardiology: utilization and costs of care.
    Steinwachs DM; Collins-Nakai RL; Cohn LH; Garson A; Wolk MJ
    J Am Coll Cardiol; 2000 Mar; 35(4):1092-9. PubMed ID: 10732913
    [No Abstract]   [Full Text] [Related]  

  • 7. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.
    Heidenreich PA; Trogdon JG; Khavjou OA; Butler J; Dracup K; Ezekowitz MD; Finkelstein EA; Hong Y; Johnston SC; Khera A; Lloyd-Jones DM; Nelson SA; Nichol G; Orenstein D; Wilson PW; Woo YJ; ; ; ; ; ; ; ; ; ; ; ; ;
    Circulation; 2011 Mar; 123(8):933-44. PubMed ID: 21262990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of occupational circulatory disease.
    Leigh JP; Schnall P
    Occup Med; 2000; 15(1):257-67, v. PubMed ID: 10702089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs tied to many issues.
    Bove VM
    Physician Exec; 1992; 18(5):23-9. PubMed ID: 10121673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of cardiac care likely to increase, despite advances in prevention, care.
    Kuehn BM
    JAMA; 2013 Nov; 310(19):2029. PubMed ID: 24240914
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart Disease Prevalence, Medical Costs Will Soar in US by 2050.
    Harris E
    JAMA; 2024 Jul; 332(4):273. PubMed ID: 38941123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular diseases in the focus of health economics. The example of drug-eluting vascular stents in coronary heart disease].
    Reinhold T; Müller-Riemenschneider F; McBride D; Brüggenjürgen B; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):693-9. PubMed ID: 22526858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of cardiovascular disease burden in the United States.
    Mensah GA; Brown DW
    Health Aff (Millwood); 2007; 26(1):38-48. PubMed ID: 17211012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of cardiovascular disease in the United States.
    Chen J; Rizzo JA
    Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac rehabilitation. Increased referrals can decrease mortality, morbidity and costs.
    Privette T
    Adv Nurse Pract; 2002 Jan; 10(1):79-80. PubMed ID: 12420518
    [No Abstract]   [Full Text] [Related]  

  • 17. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs.
    Yazdanyar A; Newman AB
    Clin Geriatr Med; 2009 Nov; 25(4):563-77, vii. PubMed ID: 19944261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Burden of Heart, Lung, and Blood Diseases in the United States, 1990 to 2016: Perspectives from the National Heart, Lung, and Blood Institute.
    Coles E; Mensah GA
    Glob Heart; 2017 Dec; 12(4):349-358. PubMed ID: 29179889
    [No Abstract]   [Full Text] [Related]  

  • 20. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
    Luengo-Fernandez R; Leal J; Gray AM
    Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.